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Goals of the paper were to use item response theory (IRT) to assess the relation of depressive
symptoms to the underlying dimension of depression and to demonstrate how IRT-based
measurement strategies can yield more reliable data about depression severity than conventional
symptom counts. Participants were 3403 clinic and nonclinic children and adolescents from 12
contributing samples, all of whom received the Kiddie Schedule of Affective Disorders and
Schizophrenia for school-aged children. Results revealed that some symptoms reflected higher
levels of depression and were more discriminating than others. Results further demonstrated that
utilization of IRT-based information about symptom severity and discriminability in the
measurement of depression severity can reduce measurement error and increase measurement
fidelity.
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The application of item response theory (IRT) to semi-structured clinical interview data can
simultaneously advance our understanding of psychopathology and enhance the fidelity of
its measurement. IRT has proven useful when applied to paper-and-pencil measures of
depressive symptoms (Bedi, Maraun, & Chrisjohn, 2001; Cassano et al., 2009; Sharp,
Goodyer, & Croudace, 2006; Waller, Compas, Hollon, & Beckjord, 2005). For clinical
researchers, the closest thing to a gold standard for the assessment of child and adolescent
depression is a semi-structured clinical interview, typically administered not just to the child
but to a parent or other caregiver as well. As such, the semi-structured clinical interview is
inherently a multi-method assessment system, filtering information from multiple
informants through interviewers with clinical training and expertise. Analyzing symptom-
level information derived from such measures can provide insights into the structure of the
underlying depression construct, lead to the psychometric enhancement of these measures,
and eventually enable researchers to derive more information from such interviews of
depressed children and adolescents. Although IRT analyses have been conducted with adult
samples (e.g., Simon & Von Korff, 2006), relatively few IRT analyses of clinical interview
data have been conducted with child or adolescent populations (e.g., Small et al., 2008).
In both child and adult populations, conventional factor analyses have informed our
understanding about the relation of specific depression symptoms to the underlying latent
variable (Aggen, Neale, & Kendler, 2005; Ryan et al., 1987). IRT provides at least three
additional kinds of information. First, IRT links each symptom to a specific level of
depression severity. Consider an analogy. On a math test, some items may be more difficult
than others, such that passing a more difficult item may suggest that the respondent has a
higher level of math ability than does passing an easier item. The same may be true for
depressive symptoms. Some symptoms may be evident at relatively mild levels of the
disorder, whereas other symptoms may only emerge at very severe levels. In other words,
severe depression may be characterized by symptoms that are not often evident in mild
depression. Assessing depression severity simply by counting the number of symptoms
treats all symptoms as though they were of equal severity or importance and potentially
ignores other valuable information that can be derived from the assessment process.
Second, IRT allows for the possibility that all symptom ratings may not be equally reliable
or discriminating indicators of depression. Some symptoms may be strong indicators of
depression, constituting core characteristics of the disorder. Other symptoms may be less
strongly related to depressive disorder or may be relatively nonspecific signs of the disorder.
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Unlike methods based on classical test theory, IRT-based estimates of item (or symptom)
discriminability are not sample dependent once the IRT model is calibrated (Reise & Waller,
2009). That is, the psychometric properties of the items do not vary from sample to sample
but generalize to all samples from the same population, revealing something about the
structure of the underlying latent dimensions in general. Furthermore, utilization of IRT-
derived discriminability information (in conjunction with severity information) can greatly
enhance the fidelity of the information that can be derived from clinical interview data.
Third, the application of IRT to a collection of symptoms enables researchers to ascertain
the degree to which a measure “covers” the latent variable. That is, IRT reveals how
informative a measure is at all levels of the underlying dimension. Some measures may be
particularly discriminating at the high end of depression severity and be especially useful in
clinical settings. Other measures may be maximally discriminating at the low end of
depression severity and be useful as a screening device in nonclinical populations. When a
measure is used in clinical trials, it should be discriminating along the entire range of
severity, because participants typically start at very high levels of the disorder but
(hopefully) end up at much lower levels.
When symptoms of a disorder (as assessed by a semi-structured clinical interview) are
treated as “items” in an IRT analysis, these three kinds of information simultaneously serve
two purposes. First, they teach us more about the relations of symptoms to the underlying
depression factor(s). And second, they can be used in the construction of new indices (and
even computer adaptive testing methods) that are more efficient and more discriminating
across a wider range of the targeted dimension. IRT has often resulted in tests that are
shorter and more sensitive to the detection of individual differences (Gibbons et al., 2008;
Reeve, Burke et al., 2007; Reeve, Hays et al., 2007). Clinical applications of IRT are rare,
largely because IRT requires sample sizes that are substantially larger than are available in
most clinical data bases. Of the few such studies that do exist, almost all have focused on
paper-and-pencil measures of psychopathology, on which large samples can more easily be
obtained (Cassano et al., 2009; Fliege et al., 2009; Gardner et al., 2004; Gibbons et al.,
2008). To solve the sample size problem, we aggregated data from clinical researchers in the
United States and Great Britain who used the Kiddie Schedule of Affective Disorders and
Schizophrenia for school-aged children (K-SADS) to measure major depressive disorder
(MDD) in children and adolescents. We intentionally sought a wide variety of data sets
including community samples, high risk samples, and clinical treatment samples, so that
collectively they would represent all levels of depression severity. We also sought samples
that would contribute to the demographic diversity of the composite data set, in terms of age,
sex, and ethnicity.
Thus, the present study had three goals or hypotheses. First, we anticipated that the presence
of some depressive symptoms would reflect a more severe underlying depressive disorder
than would the presence of other symptoms. For example, we hypothesized that depressed
mood would be a relatively mild symptom (as it is widely regarded as the core or gateway
symptom of MDD), whereas suicidal ideation would be a more severe symptom, tending to
manifest itself at relatively severe levels of the disorder. Second, we expected items to
evince different levels of discriminability, with some being highly reflective of the
underlying disorder (e.g., anhedonia (Clark & Watson, 1991; Lonigan, Carey, & Finch,
1994)) and others being only moderately reflective of the condition (e.g., weight/appetite
disturbance) – perhaps because they are also characteristic of other disorders. The third goal
was to examine the degree to which an IRT-based scoring of the K-SADS would yield more
reliable symptom ratings and would generate more information compared to conventional
methods of scoring the K-SADS to measure depression severity.
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Three criteria were required for a data set to be included in the study. First, it had to contain
symptom-level information either about participants’ current state or their recent episode of
MDD, derived from K-SADS interviews with children and parents. Second, participants had
to be 5 to 18 years old. Third, the K-SADS data must have been collected prior to any
treatment or preventive intervention. Prior to data acquisition, we obtained IRB approval,
arranged for the complete de-identification of data sets, made explicit the limitations on our
use of the data, conferred with the PI and other study collaborators to ensure that no
conflicts of interest existed between our research agenda and those of the original
investigator(s), discussed authorship, and obtained signed letters of agreement from the PI or
co-PI of each project.
In total, we obtained 12 different data sets, yielding a total of 3403 participants. We refer to
each study by the investigator who was our key collaborator on this project. When this
person provided access to multiple data sets, we use the study title as well. Contributors
included the following: Cole (Cole et al., in press), Compas and Forehand (Compas et al.,
2010; Compas et al., 2009), Curry (TADS, 2003, 2005), Findling (Findling et al., 2005;
Youngstrom et al., 2004a; Youngstrom et al., 2005), Garber (Garber et al., 2009; Garber,
Keiley, & Martin, 2002; Garber & Robinson, 1997; Garber, Weiss, & Shanley, 1993),
Goodyer (Goodyer et al., 2007, 2008), Hyde and Essex (Essex et al., 2006; Essex et al.,
2009; Grabe, Hyde, & Lindberg, 2007), Rohde (N. Kaufman, Rohde, Seeley, Clarke, &
Stice, 2005; Rohde, Clarke, Mace, Jorgensen, & Seeley, 2004; Rohde, Seeley, Kaufman,
Clarke, & Stice, 2006), Stark (Fisher, 2010), Weissman (Pilowsky et al., 2008; Weissman,
Pilowsky, & Wickramaratne, 2006), and Youngstrom (Findling et al., 2005; Youngstrom et
al., 2004a, 2004b; Youngstrom et al., 2005). Key characteristics of the data sets appear in
Table 1.
Measures
Several versions of the K-SADS were used in the contributing studies. These included K-
SADS-PL (J. Kaufman et al., 1997), K-SADS-PL version 1.0 (J. Kaufman, Birmaher, Brent,
Rao, & Ryan, 1996), K-SADS-E (Orvaschel, 1994), WASH-U-K-SADS (Geller, Zimerman,
& Williams, 2001), and K-SADS-IVR (Ambrosini & Dixon, 1996). When K-SADS data
were available for multiple episodes of major depression, we focused on the current or most
recent episode. All 5 K-SADS versions provide lines of inquiry and example questions for
interviewers to use with children (about their own symptoms) and with parents (about their
child’s symptoms). Slight differences exist in the example questions; however, no version
insists that the interviewer adhere to the exact questions that are listed. In fact, all versions
recommend that interviewers utilize their clinical skills to probe in ways that the participants
can understand.
Because the DSM-IV TR regards irritability/anger as evidence of mood disturbance in
children, we treated it as a separate symptom in the current study. Pooling across the 5
versions of the K-SADS, examples of questions for assessing the depressive symptoms
included:
1. Depressed mood. Have you ever felt sad, blue, down, or empty? Did you feel like
crying? Did you have a bad feeling all the time that you couldn't get rid of?
2. Irritability/anger. Was there ever a time when you got annoyed, irritated, or cranky
at little things? Did you ever have a time when you lost your temper a lot?
Cole et al. Page 4













3. Pervasive anhedonia (lack of interest, apathy, low motivation, or boredom). Has
there ever been a time you felt bored a lot of the time? Did you have to push
yourself to do your favorite activities? Did they interest you?
4. Weight/appetite disturbance. (a) Appetite loss: How is your appetite? Do you feel
hungry often? Do you leave food on your plate? Do you sometimes have to force
yourself to eat? (b) Weight loss: Have you lost any weight since you started feeling
sad? Do you find your clothes are looser now? (c) Appetite gain: Have you been
eating more than before? Is it like you feel hungry all the time? (d) Weight gain:
Have you gained any weight since you started feeling sad? Have you had to buy
new clothes because the old ones did not fit any longer?
5. Sleep disturbance. (a) Insomnia: Do you have trouble sleeping? How long does it
take you to fall asleep? Do you wake up in the middle of the night? Do you wake
up earlier than you have to? (b) Hypersomnia: Are you sleeping longer than usual?
Do you go back to sleep after you wake up in the morning?
6. Psychomotor disturbance. (a) Agitation: Since you've felt sad, are there times when
you can't sit still, or you have to keep moving and can't stop? Do people tell you not
to talk so much? (b) Retardation: Since you started feeling (sad) have you noticed
that you can't move as fast as before? Has your speech slowed down? Have you felt
like you are moving in slow motion?
7. Fatigue, lack of energy, tiredness. Have you been feeling tired? Do you take naps
because you feel tired? Do you have to rest? Do your limbs feel heavy? Is it very
hard to get going? … to move your legs?
8. Self-perceptions. (a) Worthlessness: How do you feel about yourself? Do you like
yourself? Do you ever think of yourself as pretty or ugly? Do you think you are
bright or stupid? (b) Excessive/inappropriate guilt: Do you feel guilty about things
you have not done? or are actually not your fault? Do you feel you cause bad things
to happen? Do you think you should be punished for this?
9. Cognitive disturbance. (a) Concentration, inattention, slowed thinking: Sometimes
children have a lot of trouble concentrating, like [list examples]. Have you been
having this kind of trouble? Is your thinking slowed down? When you try to
concentrate on something, does your mind drift off to other thoughts? Can you pay
attention in school? Can you pay attention when you want to do something you
like? (b) Indecision: When you were feeling sad, was it hard for you to make
decisions?
10. Suicide. Sometimes children who get upset or feel bad wish they were dead or feel
they'd be better off dead. Have you ever had these types of thoughts? Sometimes
children who get upset or feel bad think about dying or even killing themselves.
Have you ever had such thoughts? How would you do it? Did you have a plan?
All versions had good inter-rater reliability in the studies that contributed data. Previously
accumulated validity information supports the use of all versions of the K-SADS to measure
and diagnose depression (Ambrosini, 2000). The K-SADS-PL and -E versions are primarily
categorical diagnostic interviews, whereas the WASH-U and K-SADS-IV-R measure
symptom severity and are sometimes used to measure degree of treatment response
(Ambrosini, 2000). The various versions of the K-SADS also differ in the scaling used to
quantify symptom severity. The K-SADS-PL uses a 3-point scale, where 1 = symptom is
absent, 2 = symptom is present at a subclinical level, and 3 = symptom is severe and
frequent enough to be at or above threshold. Other versions of the interview use 4-, 6-, and
7-point scales. All versions provide explicit severity and frequency anchors for their scales.
These anchors enabled us to translate all measures onto the 3-point K-SADS-PL scale. We
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converted the 6-point K-SADS-IVR scale such that 1–2=1, 3=2, and 4–6=3.1 We converted
the 4-point Orvaschel versions of the K-SADS such that 1=1, 2=2, and 3–4=3. We
converted a 7-point version of the K-SADS-PL such that 1–3=1, 4=2, and 5–7=3. And we
modified the WASH-U-K-SADS such that 1–2=1, 3=2; 4–7=3. Our data analytic method
(see below) utilized a multi-group approach enabling us to confirm the psychometric
equivalence of the resultant scales across studies.
Variables—We extracted four kinds of variables from the K-SADS data. The first was a
collection of symptom-specific variables (on the 1–3 scales described above). The second
was a dichotomous index of presence or absence of MDD, reflecting DSM-IV TR criteria
(using only “above-threshold” symptoms). Third was a raw symptom count variable,
ranging from 0 – 10, reflecting presence or absence of the ten depression symptoms (also
using only above-threshold symptoms). Fourth was a raw symptom sum variable, equal to
the sum of the ten 3-point symptom-specific variables.
Missing data—Three different patterns of missing data occurred across the contributing
data sets. Pattern 1 (10% of the cases) emerged because some studies used questions about
depressed mood, irritability, and anhedonia as screening questions and did not ask about the
remaining depressive symptoms (presumably because they did not meet criteria on the
screening symptoms). Pattern 2 (12.5%) emerged because in some studies participants were
asked the first screening questions plus the suicide screening question but were not asked
about other symptoms. Pattern 3 (5%) consisted of random missing data. Comparisons of
participants with each pattern of missing datat to the larger pool of participants with no
missing data revealed no psychometric differences between the groups. Consequently, we
did not exclude participants with partial data, but used an expectation-maximization (EM)
algorithm for the multiple group full-information maximum marginal likelihood estimation
that utilized all available data (Bock & Aitkin, 1981).
Results
Descriptive statistics
Overall, the composite data set contained information on 1722 boys and 1678 girls (3 were
missing on gender). Ages ranged from 5 to 18 years (M=12.39, SD=2.99). See Table 1. The
sample was ethnically diverse: with 66% Caucasian, 24% African-American, 4% Hispanic,
and 6% other. All were English speaking. Means and SDs for all symptom variables and the
total symptom count appear in Table 2.
Testing Unidimensionality and Local Independence
Two closely related assumptions of IRT are unidimensionality of the symptoms and the
absence of noteworthy local dependencies between the symptoms after accounting for the
primary underlying factor (Reise & Waller, 2009). We used categorical weighted least
squares confirmatory factor analysis and IRT methods to test these assumptions.
Specifically, we constrained all symptoms to load only onto a single underlying factor,
allowing no correlations among the disturbances. Although the overall chi-square was
significant, χ2(35) = 142.71 (p < .001), other fit indices clearly revealed that the fit was
excellent: CFI = 0.99, NFI = 0.99, and RMSEA = 0.035 (90% confidence interval of 0.030
– .059), suggesting that the model fit the data well (Browne & Cudeck, 1993). Factor
loadings appear in Table 3. Further, the root mean square of the residuals was only 0.036.
Eigenvalues of the estimated polychoric correlation matrix were 7.54, 0.51, 0.41, 0.30, 0.29,
1Consultation with experts suggested one exception. Suicide was scaled such that 1=1, 2=2, and 3–6=3.
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0.26, 0.23, 0.19, 0.15, and 0.12. Taken together, these results provide strong support for the
unidimensionality of the depressive symptoms. We also conducted an exploratory full-
information factor analysis (Bock, Gibbons, & Muraki, 1988) using IRTPRO. Extracting
two factors (in an oblique, direct quartimin rotation) revealed evidence of over-factoring
(i.e., the second factor had only one large loading, as shown in Table 3). Finally, Chen and
Thissen’s (1997) local dependence indices showed no discernable pattern across all item
pairs, suggesting no evidence of nuisance factors.
IRT Analyses
General analytic approach—Our primary analytic approach consisted of a multi-group,
unidimensional, graded IRT model. We arbitrarily selected one of the contributing datasets
(Garber-2) to serve as the reference group in this analysis. We used Samejima’s (1969)
graded response model because it is specifically suited to examining the 3-point ratings for
each symptom (absent, subclinical, clinical). We used IRTPRO (Cai, du Toit, & Thissen, in
press) to estimate these models. We relied on Orlando and Thissen’s (2000) summed-score
item-fit statistics and plots to test the misfit in the shape of item response characteristic
curves. In every case, we found that the model-expected probabilities closely followed the
observed response probabilities.
Cross-study comparisons—By design, we selected highly heterogeneous data sets. By
examining them directly in a multiple-group model, we demonstrated that we can
successfully capture this heterogeneity (see Figure 1).2 Note that all distributions are plotted
on a common metric for the latent depression variable. In IRT (as in common factor
analysis), this metric is arbitrary. In the current application, we set the reference group mean
at 0 and the SD at 1. We then mapped all the other groups onto this metric. Because many of
the other groups contained more seriously depressed participants, the mean and SD of the
combined sample were greater than those for the reference group. For the combined sample,
the mean of the IRT scale score was 2.60 and the SD was 1.28. Aided by the availability of
the MDD diagnosis variable in our data sets, we found that a score of 4 on the latent
depression scale corresponded to a level of depression associated with a 0.85 predicted
probability of having MDD in a logistic regression of MDD on depression scale scores.
Using this metric, we plotted the estimated depression distributions for all contributing data
sets, which collectively span the entire range of the underlying latent depressive continuum
(with nonclinical samples falling at the lower end of the scale and samples with more
seriously depressed participants falling at the higher end; see Figure 1). Such breadth
allowed us to assess the relation of symptom to depression across the entire range of the
latent variable. More importantly, such heterogeneity ensures greater generalizability
compared to most single-sample investigations.
Next, we conducted differential item function (DIF) tests to detect non-invariance of item
parameters across the studies.3 Of the tested items, we found no significant differences in
the item characteristic curves, providing evidence of invariance across samples despite the
2The Hyde/Essex data set and Findling data set were each divided into two data sets, as slightly different versions of the K-SADS
were used for different subsets of the participants.
3Because there are more than a dozen groups in the analysis, the use of IRT-based Likelihood Ratio (IRT-LR) DIF procedure (Thisen,
Steinberg, & Wainer, 1993) is too cumbersome. Instead, we relied on the more flexible and asymptotically equivalent Wald DIF test
to examine the degree to which the items exhibit cross-study differences in thresholds or discrimination parameters. For anchoring, we
adopted the IRT-LR DIF convention of using all items other than the studied item as the anchor set. Due to the combination of study-
specific skip patterns and missing data, some items only had a few observed responses in some studies, leading to some DIF runs with
non-converged solutions. Given this limitation, we were still able to conduct DIF tests for 6 out of the 10 symptoms (Depressed mood,
Irritability, Anhedonia, Weight/appetite disturbance, Sleep disturbance, Worthlessness/guilt). There was no indication of statistically
significant DIF for the symptoms tested.
Cole et al. Page 7













use of different interviewers and different versions of the K-SADS. To the extent supported
by the statistical results, the lack of DIF shows that our conversion of all K-SADS measures
to 3-point scales yielded psychometrically equivalent metrics, thereby paving the way for
tests of our more substantive hypotheses.
As shown in Figure 2, the study-specific standard error of measurement (SEM) curves
convey the precision of the K-SADS at all points along the latent depression continuum.
Particularly noteworthy is that the curves are horizontally aligned with one another,
revealing that for all studies scores from the K-SADS measure of depression were most
reliable between scores of 3.1 and 5.6 on the latent depression variable. Between these
values, all studies had small SEMs, ranging from 0.26 to 0.50 on the Y-axis. Also important
is the fact that this “high-reliability window” contains the value of 5.0 on the X-axis, the
approximate threshold for an MDD diagnosis. At lower and higher levels of depression, the
K-SADS symptom scores begin to provide a less reliable index of depression severity, as
indicated by the upward curves of the SEM lines. For people with fewer than 2 symptoms or
more than 7, the SEMs begin to exceed 1.0 on the Y-axis.4
Overview of main results—The relation of each symptom (and the various K-SADS
response options) are represented by a set of response curves. As shown in the example
curves in Figure 3, each symptom has three curves. The descending curve on the left
represents the probability of obtaining a score of 1 (i.e., symptom is absent), as a function of
the latent depression level. We would expect these probabilities to drop sharply as the level
of depression increases. The rising and falling curve in the middle represents the probability
of a 2 (i.e., symptom is subclinical). We would expect these probabilities to be near zero at
both the low and high ends of the depression continuum. The rising curve at the right
represents the probability of a 3 (i.e., symptom is present at a clinically significant level).
We would expect these probabilities to rise sharply at higher levels of the latent depression
variable. The point where the descending curve reaches .50 is called “threshold 1” and the
point where the rising curve meets .50 is called “threshold 2.” These reflect symptom
severity. The overall steepness of these curves reflects how sharply a symptom discriminates
between different levels of depression. In the hypothetical examples of Figure 3, panel A
represents a low-severity low-discriminability symptom, panel B represents a high-severity
low-discriminability symptom, panel C represents a low-severity high-discriminability
symptom, and panel D represents a high-severity high-discriminability symptom. Response
curves for the actual symptoms appear in Figure 4, and the associated symptom threshold
and discrimination parameters are the focus of the next sections.
Question 1: Are some depressive symptoms reflective of more severe
depression than others?—We estimated the severity thresholds for each symptom.
Then we used the symptom parameter covariance matrix, produced by IRTPRO using a
Supplemented EM algorithm (Cai, 2008), to compute the SEs around the severity threshold
estimates. With this information, we determined the rank order of the depressive symptom
severities. Table 4 contains estimates of thresholds 1 and 2 and their SEs. The final column
of Table 4 indicates the rank order of the symptom severities, based on the second set of
threshold estimates.
According to these data, clinically significant concentration problems, worthlessness/guilt,
and sleep disturbance emerge at the lowest levels of depression severity, followed by
problems related to depressed mood, fatigue/energy, irritability, and anhedonia. At still
higher levels of depression severity, psychomotor agitation/retardation, weight/appetite
4Because some studies in our sample have much larger or smaller variability than the reference group with an assumed variance of
one, the study-specific SEMs can be either larger or smaller than 1.0.
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disturbance, and suicidal ideation/attempts emerge – with each signaling a significantly
higher level of depression severity.
These results raised the possibility that concentration problems, worthlessness/guilt, and
sleep disturbance might serve as a better screening cluster than depressed mood, irritability,
and anhedonia (the symptoms used as screeners in some applications of the K-SADS).
Consequently, we compared sensitivity/specificity analyses for the two symptom clusters.
Using DSM-IV diagnosis of MDD as the criteria, however, would bias these results in favor
of the conventional screeners, as DSM-IV requires at least one of these three symptoms for
an MDD diagnosis. Instead, we used number of symptoms as the criterion. As shown in
Table 5, the unconventional screeners have slightly better sensitivity than the conventional
screeners. With the illness criterion set at ≥5 MDD symptoms, the unconventional screeners
would catch 99.3% - 98.6% = 0.7% more cases than would the conventional criteria. In the
current data set, this translated into 8 more cases. Of course, this advantage comes at the cost
of lower specificity. With the illness criterion again set at ≥5 MDD symptoms, the
conventional screeners would have correctly categorized 78.6% - 70.6% = 8.0% more of
people who did not have the illness, compared to the unconventional screeners. In the
current data set, this translated into 114 more cases.
Question 2: Are some symptoms more discriminating indicators of
depression than others?—To estimate the strength of relation between each symptom
and the underlying latent variable, we examined the discrimination parameters and factor
loadings for each symptom (see Table 6). The item discrimination parameters can be
interpreted as logistic regression slopes, or log odds-ratios. Examination of these parameters
and their associated factor loadings (using conversion formulae in Wirth & Edwards, 2007)
revealed that all of the K-SADS items are highly discriminating indicators of depression.
Even the smallest slope (suicidal ideation) is associated with depression at an odds ratio of
2.36. Examination of the overlap (and the gaps) between the confidence intervals around the
slopes revealed that some symptom indicators are more discriminating than others.
Depressed mood and anhedonia were the most discriminating indicators. The next most
discriminating set of indicators included fatigue/lack of energy, irritability, and
concentration problems. The third most discriminating set consisted of sleep disturbance,
worthless/guilt, psychomotor agitation/retardation, followed by weight/appetite disturbance.
The least discriminating symptom was suicidal ideation.
Question 3: How much more information can be gleaned from K-SADS
interview data using IRT-based estimates of depression?—One way to address
this question is to compare four indices of depression severity. First was the raw symptom
count (simply the number of DSM symptoms of depression that were coded as present).
Second was the raw symptom sum (the raw sum of the ten 3-point symptom variables).
Third was called IRT-2, an IRT-based expected a posteriori (EAP) index based on the 2-PL
model utilizing only two levels of information about presence or absence of the symptoms.
And the fourth was called IRT-3, an IRT-based EAP index based on the graded model
utilizing all three levels of severity for each symptom. We made this comparison by
estimating the SEM for each index at varying levels of the latent depression variable. We
estimated the SEM curves for the two IRT-base indices using the posterior standard
deviations of the scale scores (Thissen & Wainer, 2001). We estimated crude SEM curves
for the two non-IRT indices by applying the formula, , where
reliability was Cronbach’s alpha for the selected index computed repeatedly for subsamples
representing a sliding 2-SD-wide window on the latent depression variable.5
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The four SEM curves are depicted in Figure 5. At any given level of the latent variable (i.e.,
various points along the X-axis), a smaller SEM signifies greater measurement fidelity.
Visual examination of this figure revealed two important findings. First, both of the IRT-
based indices have lower SEMs than both of the non-IRT indices at virtually all levels of the
latent depression variable. That is, using IRT-derived information about symptom severity
and discriminability substantially enhances precision in the measurement of depression
severity. Second, both of the indices that utilized information about subclinical levels of
depressive symptoms (i.e., the raw symptom sum and the IRT-3) were superior to both of
the indices that ignored such information (i.e., raw symptom count and IRT-2). That is, both
the symptom sum index and the IRT-3 index had lower SEMs than the symptom count and
IRT-2 index, respectively, especially at lower levels of the latent depression variable.
A second way to address this question is to examine the amount of information that is lost
when one uses more conventional nonIRT-based indices of depression severity. A simple
symptom count does not take into consideration the fact that some symptoms reflect greater
depression severity than others. We can visualize the degree to which this is true by
examining histograms depicting the range of IRT-based latent depression scores at each
level of a more conventional symptom-count variable (see Figure 6). For people with a raw
symptom count of 1, latent depression scores ranged from 0.7 to 3.6. For people with a raw
count of 8, latent depression ranged from 4.1 to 5.8 (with an SD = 1.28 for the latent
depression variable). This means that the variability of latent depression scores spanned
approximately 1 to 2 SDs at each whole number value of the raw symptom count. That is,
the raw symptom count gives identical scores to people with highly discrepant levels of
latent depression – a process that results in a substantial loss of information.
Discussion
Four major findings about the K-SADS and depressive symptoms in children and
adolescents emerged from this study. First, our K-SADS depression data were remarkably
unidimensional. Second, some symptoms of depression emerged at relatively mild levels of
the disorder; others emerge when depression was much more severe. Third, in children and
adolescents, all K-SADS symptoms of depression were strongly associated with depression.
And fourth, higher fidelity and better coverage of the construct derived from assessment
algorithms that take IRT-based estimates of symptom severity/discriminability into account
and utilize information about subclinical levels of symptom severity. These findings have
important clinical and theoretical implications.
Our first major finding was that a very strong single latent variable emerged from our K-
SADS data on symptoms of depression. Based on our confirmatory factor analysis, loadings
for the 10 symptoms were strong, ranging from 0.95 (depressed mood) to 0.73 (suicide).
This factor accounted for 75.4% of the covariance among the 10 symptoms. The fact that no
evidence of secondary factors emerged (not even nuisance factors) is unusual for measures
of depression; however, most measures of depression are questionnaires in which many
symptoms are represented by multiple items. For example, the Children’s Depression
Inventory (Kovacs, 1985) contains 3 mood items, 2 anhedonia items, 2 guilt items, 4 self-
esteem items, etc. This creates a complex structure with a number of small factors caused by
parcels of item content (Cole, Hoffman, Tram, & Maxwell, 2000). Indeed, when such
5The availability of the IRT scale scores, as realizations of the “true scores” of the underlying depression latent variable, enables us to
make the comparison between the reliability of raw symptom sums/counts and the reliability of the IRT scale scores. Each IRT scale
score, whether it is IRT-2 or IRT-3, has an associated standard error of measurement. As for the raw symptom sums or counts, we
calculated their reliability by treating the symptoms as observed variables in a scale and utilized a traditional summed-score-based
internal consistency reliability estimator (KR-21 or Cronbach’s alpha). The curves in Figure 5 for symptom sums or counts were
smoothed to eliminate the effect of distributional discontinuities.
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measures are exceptionally unidimensional, one begins to wonder if the items are too similar
to one another, causing the underlying factor to be overly narrow. In the KSADS,
interviewers also ask multiple questions about each symptom, but then they aggregate each
cluster of questions into a single appraisal about a particular symptom. This procedure
greatly reduces the likelihood that nuisance factors will emerge. As the content of each item
is highly distinctive (depressed mood, appetite disturbance, sleep disturbance, suicide,
psychomotor agitation/retardation, irritability, fatigue/lack of energy, guilt/low self-esteem,
concentration problems, and anhedonia), the resulting factor is anything but narrow. Given
the strong, prima facie, one-to-one correspondence of KSADS depression items to DSM-IV
depression symptoms, the emergence of a strong single factor suggests that the core
symptoms of depression correlate with one another only because of a single underlying
dimension of psychopathology, arguably depression.
Second, some DSM-IV symptoms are present at significantly lower levels of depression
severity than are others. At relatively low levels of the latent dimension (below the threshold
for a diagnosis of MDD), clinically significant symptoms of concentration problems,
worthlessness/guilt, and sleep disturbance were evident. At slightly higher levels of the
latent variable (and still below the MDD threshold), symptoms of depressed mood, fatigue,
irritability, and anhedonia were evident. At still higher levels of depression (and above the
MDD cutoff), psychomotor agitation/retardation, weight/appetite disturbance, and suicidal
ideation/attempting became increasingly likely, with each reflecting a clinically and
statistically significant increase in severity on the latent variable.
Our expectation that the required symptoms of MDD (depressed mood, irritability, or
anhedonia) would emerge at the lowest levels of the latent variable was not confirmed. In
children and adolescents, concentration problems were evident at significantly lower levels
of depression than were all three affective symptoms. Worthlessness/guilt and sleep
disturbance were not significantly different from concentration problems. Taken together,
these results suggest that concentration problems, worthlessness/guilt, and sleep disturbance
may represent early warning signs for MDD. This possibility, however, would not seem to
warrant changing the K-SADS screening criteria, as the relatively small (0.7%) gain in
sensitivity comes at a much larger (8.0%) loss of specificity.
In a related vein, our results also showed that the occurrence of some symptoms signifies a
much greater level of depression severity than does the occurrence of other symptoms. For
example, the occurrence of worthlessness/guilt or sleep disturbance represents a very small
increase in depression severity over-and-above concentration problems, whereas the
presence of psychomotor agitation/retardation, weight/appetite problems, or suicidal
ideation/attempting represents substantially higher levels of severity. To our knowledge, no
K-SADS measurement algorithm makes use of this kind of information, which could
substantially enhance the fidelity of depression severity assessments.
Third, all DSM-IV symptoms were strong indicators of depression in children and
adolescents; however, some symptoms were more strongly related to the depression factor
than others. Depressed mood was by far the strongest indicator, such that a 1-point change in
the latent variable was associated with a 15-fold increase in the probability of the symptom.
Anhedonia was the next most discriminating symptom, followed by fatigue/energy,
irritability, and concentration problems. Suicidal ideation/attempt was the least
discriminating symptom. This kind of information can be used to enhance the measurement
of depression severity (Weiss, 1982, 1985).
Interestingly, a trade-off appears to exist between severity and discriminability of depressive
symptoms as indicators of depression, with the less discriminating items emerging at higher
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levels of depression severity. The correlation between severity and discriminability
estimates was −0.64. For example, suicidal ideation/attempting, weight/appetite disturbance,
and psychomotor agitation/retardation were among the most severe yet least discriminating
symptoms. Conversely, depressed mood and concentration problems were among the less
severe but more discriminating symptoms. An ideal method of measurement would take
both severity and discriminability into consideration.
Fourth, to do this, we constructed two IRT-based K-SADS indices of depression severity;
one was based on just the presence/absence of symptoms, whereas the other utilized
information about subclinical symptoms as well. Both indices out-performed more
conventional scoring methods that were simply based on symptom counts or summed
scores. Psychometric comparisons revealed that scores from the IRT-based measures were
more reliable and had lower SEs, especially in the moderate to severe range of depression.
Furthermore, utilizing subclinical symptom information extended these psychometric
advantages further into the mild range of depression. In other words, using IRT methods and
incorporating information about subclinical symptom levels increased both the fidelity and
band-width of measurement.
These results have two noteworthy implications. First, IRT-based increments in
measurement fidelity (i.e., reduced measurement error) can readily translate into larger
between- and within-group effect sizes and therefore greater statistical power to detect
treatment effects, as shown in at least one randomized treatment-control study on the
effectiveness of antidepressants (Santor, Debrota, Engelhardt, & Gelwicks, 2008). Second,
the IRT-based inclusion of subclinical symptom information and the resultant increased
band-width can be especially helpful in treatment-comparison research. When one treatment
is compared to another, a large part of the effect can depend upon differences that reside in
the subclinical range of the dependent variable. The inclusion of even one extra response
option to indicate the subclinical presence of each symptom can substantially enhance the
researcher’s capacity to detect a treatment difference. Whether the inclusion of even more
response options could generate more power is an interesting question worthy of further
investigation.
At least four shortcomings of the current study suggest avenues for future research. First, all
of the IRT analyses in this study focused on data obtained by using the K-SADS. Although
this measure utilizes information from multiple informants, filtered through the expertise of
well-trained clinical interviewers, the K-SADS still represents only a single method for
measuring depression. As such, it is possible that the strong latent variable that emerged
from our analyses represents not just depression but also this method. Although semi-
structured clinical interviews like the K-SADS have been touted as the closest thing to a
gold standard that mental health researchers have in the assessment of psychopathology
(Hersen & Gross, 2008), they are not immune to method effects. Although it is unlikely that
demand characteristics or interviewer bias would act similarly across all the investigative
teams that contributed data to this study, it is not impossible. For example, eager to fill the
quota of depressed participants in a research study, interviewers could be positively biased
in their perception of depressive symptoms. Replication of the current results with multiple,
methodologically dissimilar measures of depression would mitigate these concerns.
Second, our analyses carefully established the invariance of the IRT results across the
samples that contributed to the aggregate data set. This is a critical first step. It is possible,
however, that the results may not be invariant across other ways of subdividing the data.
Efforts are currently underway to examine ways that the relation of symptoms to the
underlying depression factor may vary as a function of age, gender, and ethnicity.
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Third, though we were able to use IRT methods to accomplish the cross-study linkage of
latent variable scales, our results are best treated as a first step, in the absence of further
evaluations of the quality of linking. Furthermore, we note that the means of the studies are
spread out widely across the latent depression scale, which can lead to a deterioration of the
quality of linking in the extremes.
Finally, the current study provided very strong evidence that a single underlying factor
underlies the 10 symptoms of depression as assessed by the KSADS. It is possible, however,
that this unidimensionality depends upon the level at which the symptoms of depression are
examined. We focused on symptom clusters, as recommended in the DSM-IV for the
diagnosis of MDD. Specific examples include, negative self-perceptions (which consist of
low self-esteem and guilt feeling), irritability/anger, sleep disturbance (hypersomnia and
insomnia), psychomotor symptoms (agitation and retardation), and weight/appetite
disturbance (increase and decrease). Examination of the disaggregated symptoms could
reveal evidence of one or more other dimensions.
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Distributions (probability density functions) of the contributing data sets on the latent
depression variable.
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Standard error of measurement and Fisher information curves for all contributing studies.
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Hypothetical item response curves, depicting symptoms with low vs. high severity and low
vs. high discriminability (1 = symptom is absent, 2 = symptom is present at a subclinical
level, and 3 = symptom is present at a clinical level)
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Item response curves for each symptom, where 1 = symptom is absent, 2 = symptom is
present at a subclinical level, and 3 = symptom is present at a clinical level.
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SEM curves for four indices of depression severity, as a function of the latent depression
variable.
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Histograms of latent depression levels at each level of KSADS-based symptom count index
of depression
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Table 2
Sample Descriptive Statistics for Variables Derived from the K-SADS
Variable (coded 1–3, unless
otherwise specified) Mean SD
Affective disturbance
    a. Depressed mood 1.69 0.86
    b. Irritability 1.68 0.85
Anhedonia 1.69 0.89
Weight/appetite disturbance 1.69 0.89
Sleep disturbance 1.93 0.94
Psychomotor disturbance 1.84 0.90
Fatigue, energy, tiredness 1.89 0.94
Worthlessness/guilt 1.97 0.92
Cognitive disturbance 1.97 0.94
Suicide 1.49 0.78
Raw symptom count (0–10) 2.66 3.06
Raw symptom sum (10–30) 14.93 8.01
Major depression (0,1) 0.33 0.47
*
Analytic sample N = 3403.
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Table 3






Factor 1 Factor 2
Depressed mood 0.95 0.83 0.14
Irritability 0.88 0.80 0.09
Anhedonia 0.91 0.97 −0.09
Weight/appetite disturbance 0.82 0.54 0.27
Sleep disturbance 0.87 0.80 0.04
Psychomotor disturbance 0.88 0.73 0.09
Fatigue, energy, tiredness 0.91 0.98 −0.12
Worthlessness/guilt 0.84 0.64 0.20
Cognitive disturbance 0.93 0.90 −0.02
Suicide 0.73 0.13 0.72
Note. All CFA standard errors were 0.01.
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